In this virtual event, we welcome Prof Simon Johnson from the LAM Institute to discuss ‘lymphangioleiomyomatosis’ (or ‘LAM’), a complication in the lungs that some people with TSC can get

LAM is much more common in women living with TSC compared to men, with around 3 in every 10 women living with TSC also developing LAM. It’s believed that the hormone oestrogen, which is found in greater amounts in women than men, plays a part in how LAM develops.

Come along to this event to learn more about LAM, how it develops, and what new insights the LAM Institute have had recently in diagnosing, treating and managing the condition.

Professor Simon Johnson is the National LAM Institute Lead, as well as being Head of Respiratory Medicine at Nottingham University.

If you benefit from this or other TSA events, please make a recurring or one-off donation if you can so that we can continue all of our work.